Stay updated on Mepolizumab Clinical Trial for HES & Severe Asthma
Sign up to get notified when there's something new on the Mepolizumab Clinical Trial for HES & Severe Asthma page.

Latest updates to the Mepolizumab Clinical Trial for HES & Severe Asthma page
- Check5 days agoChange DetectedThe page footer now shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedFooter now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link has been removed and Revision: v3.3.2 was deleted.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all relate to the study. Updated the revision to v3.3.2 and removed the v3.2.0 PubMed note.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved the government funding/operating status notice from the page footer.SummaryDifference0.5%

- Check77 days agoChange DetectedNo significant changes detected on the Study Details page for NCT00244686; the content remains focused on compassionate use and long-term access for mepolizumab in HES.SummaryDifference0.2%

- Check106 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference3%

Stay in the know with updates to Mepolizumab Clinical Trial for HES & Severe Asthma
Enter your email address, and we'll notify you when there's something new on the Mepolizumab Clinical Trial for HES & Severe Asthma page.